Published methods for the measurement of lignocaine in animal tissues involve homogenization before extraction of the drug into an organic solvent and subsequent gas-liquid chromatography (GLC) analysis (Svinhufvud et al., 1965; Ahmad and Medzihradsky, 1971; Benowitz and Rowland, 1973; Naito et al., 1977) . Tissue samples of at least one gram were necessary with most of these methods (Svinhufvud et al., 1965; Ahmad and Medzihradsky, 1971; Benowitz and Rowland, 1973) , although Naito et al. (1977) indicated that a sensitivity of 0-5 pg/g could be achieved if samples of approximately 0 3 g were used. However, in this latter method no lignocaine concentrations in muscle tissue were reported. Two of these methods included a solvent evaporation step (Ahmad and Medzihradsky, 1971; Naito et al., 1977) , while Svinhufvud et al. (1965) did not use an internal standard. None of the above methods gives reproducibility data for lignocaine measurements in tissue samples, and only one (Naito et al., 1977) gives the limit of sensitivity for such measurements.
The method described here was developed for the measurement of lignocaine in small (100 mg or less) samples of myocardium resulting from the multiple sectioning of artificially produced infarcts in greyhounds, in an attempt to correlate the gradient of lignocaine concentrations across an infarct with cardiac blood flow; the results are being presented Received for publication 29 August 1978 elsewhere (Wyse, R. K. H., Wittig, J. H., and Holt, D. W.-in preparation). The tissue was digested by a proteolytic enzyme, and lignocaine, together with an internal standard, was extracted into diethyl ether at an alkaline pH. Subsequently, these compounds were back-extracted into dilute acid and then reextracted into a small volume of chloroform, and a portion of the organic phase was analysed by GLC linked to flame ionisation detection. To 500 pkI of tissue digest in a 10 ml tapered glass tube 100 ,ul sodium hydroxide solution, 50 ,1 aqueous mianserin hydrochloride, and 5 ml diethyl ether were added.The tube was sealed with a ground glass stopper, and the contents were vortex mixed for 30 seconds and centrifuged in a windshielded instrument at 1800 g for 5 minutes. The ether extract was transferred by aspiration to a second tapered glass tube containing 500 ,tl sulphuric acid.
Material and methods

MATERIALS AND REAGENTS
The contents of this tube were similarly vortex mixed and centrifuged, the organic layer was removed by aspiration, and any residual solvent was eliminated under a stream of air. The solution was made basic by the addition of 300 ,ul sodium hydroxide solution, and 50 puI chloroform was added. After vortex mixing for 15 seconds, the contents of this tube were centrifuged at 1800 g for 4 minutes, and a 5 /.l portion of the organic phase was injected onto the column of the gas chromatograph. Each tissue digest was extracted in duplicate. No endogenous substances have been observed which could interfere in the analysis, and the retention time of MEGX relative to mianserin on this system was 0-27. The recovery of lignocaine added to lignocaine-free digested greyhound myocardium was 89% ± 5 6 (SD) across the concentration range 0 5-2 0 mg/l (n=9). Accordingly, the results of tissue analyses were calculated by comparing the peak height ratio in the sample with the standard calibration graph produced by the analysis of the chloroform standards, and applying a recovery factor of 1<12. If the difference between duplicate analyses was greater than 10% the analysis was repeated. The final result was expressed in terms of ,ug lignocaine/g wet weight of tissue.
The reproducibility of both the assay and sampling technique was assessed by digesting several pieces of tissue from selected regions of an infarct. Tissue containing high, intermediate, and low concentrations of lignocaine were chosen, and up to eight pieces of each were digested and then analysed in duplicate. The results are summarised in Table 1 . 59 + 14-8 48-8-82-6 6-8 ± 049 7-3 (n = 6) 3 100-± 28-9 59-3-144-2 4-2 ± 057 13-5 (n = 8)
The limit of sensitivity for the assay was I utg/g wet weight in a 100 mg sample, which was more than adequate for the range of concentrations encountered in normal myocardium through to the central area of an infarct ( Table 2 ). The animal had received a bolus of 2 mg/kg lignocaine intravenously after the induction of infarction, followed by an infusion of 5 mg/kg/h for 45 minutes; the samples were collected at the cessation of this infusion. The blood concentration of lignocaine, measured by a specific GLC method (Holt et al., 1979) , was 3-8 mg/l. Normal myocardium 100-6 13 9 Peri-infarct zone 77-1 6-7
Central infarct zone 100-1 3-2
Discussion
In order that subtle changes in lignocaine concentration within the infarct zone might be measured the samples to be measured by this method were, of necessity, small. It was felt that the published methods would result in an unacceptable loss of tissue during homogenisation, and furthermore, details of sensitivity and reproducibility for these methods were lacking. Use of the enzyme Subtilisin Carlsburg for the digestion of tissue before the extraction and measurement of drugs was described by Osselton et al. (1977) , who partially digested liver containing benzodiazepines using substantially lower concentrations of enzyme than in our method. However, it was found that the reproducibility of the present method was poor unless the tissue was digested to form a uniform suspension. For tissue samples in the range 50-150 mg, this was achieved only with high concentrations of enzyme. Osselton et al. (1977) reported a considerably higher recovery of benzodiazepines from liver samples subjected to enzymatic digestion compared with the same samples treated by acid hydrolysis. Similarly, our results for the concentration of lignocaine in normal canine myocardium are much higher than those reported by Ahmad and Medzihradsky (1971) , who analysed tissue from dogs receiving comparable doses of the drug using tissue homogenisation. This discrepancy cannot be accounted for by either the release of lignocaine from conjugates, since this is not a pathway associated with its metabolism, or interference from the metabolite MEGX. It is possible that extraction of these drugs is more complete after disruption of the tissue by enzymatic digestion. 
